Menu
Live News EQUITY M impact

ORKA: HC Wainwright Reiterates Buy

HC Wainwright & Co. reiterates buy rating on Oruka Therapeutics and maintains $120 price target

ORKA

HC Wainwright & Co.

Reiterates Buy on Oruka Therapeutics, Maintains $120 Price Target